Jeffrey Bird

Bluebird Ventures thesis

Epirium Bio Mitochondrial Biogenesis Epirium Bio is developing a new class of therapeutics that stimulates muscle growth and strength as well as benefiting biogenesis in other tissues. The Company has clinical data in several degenerative muscle disease indications including Becker’s Muscular Dystrophy. Founded by George Schreiner MD PhD and Sundeep Dugar PhD. Series A Investor and Board member Forty Seven Immuno-Oncology Forty Seven developed an antibody against CD47, a “Don’t Eat Me” signal that regulates immune activity against many cancers. Founded by Irv Weissman MD (Director of the Stanf

Sector and stage focus

• Seed: BioTech, Therapeutics
• Series A: BioTech, Therapeutics
• general: San Francisco Bay Area

Is Jeffrey Bird a fit for your round?

Upload your pitch deck and see whether Jeffrey Bird appears in your top 20 matches.